Sunny Pharmtech Aims to Submit 7 Drug License Applications This Year

2023-12-01 / GlobalBio & Investment

SunnyPharmtechAimstoSubmit7DrugLicenseApplicationsThisYear,Backedby4AdvantagesforUS-JapanStrategicCollaborationOnMay2,SunnyPharmtech(6676.TWO)heldaninvestorconference,duringwhichchairmanDr.Yon-Lian Wu...

GBIHighlights

Prix Galien Award, Nobel of Biopharmaceuticals Unveils Top Medical Products

2023-12-01 / GlobalBio & Investment

PrixGalienAward,NobelofBiopharmaceuticalsUnveilsTopMedicalProducts,fromCAR-TtoCOVID-19Vaccine.TheUKheldthePrixGalienAwardceremonyafewdaysago,whichisknownasthehighesthonorinthepharmaceuticalindustry.Th...

GBIHighlights

Dr. Frank Kung of Vivo Capital Shares US Biotech Trends

2023-12-01 / GlobalBio & Investment

Dr.FrankKungofVivoCapitalSharesUSBiotechTrends:WeaknessContinuesAfter2021Peak,BigPharmaSeeksM&A,IntenseOncology&RareDiseaseCompetitionDr.FrankKung,co-founderandexecutivedirectorofVivoCapitalre...